- Croucher Cambridge International Scholarship in 2020 at University of Cambridge
At the Cancer Research UK Cambridge Institute, he will focus his efforts on characterising drug resistance and its evolution in triple-negative breast cancer using patient-derived xenografts, with the objective of identifying strategies to overcome resistance. Triple-negative breast cancer (TNBC) is characterised by limited therapeutic options due to the absence in expression of oestrogen and progesterone receptors, and HER2. This form of breast cancer tends to be aggressive, with a poor prognosis in the recurrent or metastatic setting, where treatment resistance develops within months.
Interests in his spare time include cooking (and eating!) as well as sharing his passion for science, preferably at the same time.